Top Glove BhdTGLVY 73 EBITDA Margin % is 17.07% as of May. 2026, which is 17% above its 10-year median of 14.58. GuruFocus rates TGLVY with a GF Score™ of 73/100 and a GF Value™ of $1.19 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Top Glove Bhd ranks better than 65.07% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Top Glove Bhd's EBITDA for the
three
months ended in May. 2026 was $47.3 Mil. Top Glove Bhd's Revenue for the
three
months ended in May. 2026 was $277.2 Mil. Therefore, Top Glove Bhd's EBITDA margin for the quarter that ended in May. 2026 was 17.07%.
Top Glove Bhd (OTCPK:TGLVY) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Top Glove Bhd EBITDA Margin % Related Terms
Top Glove Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Top Glove Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TGLVY vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Top Glove Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Top Glove Bhd EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Top Glove Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Top Glove Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Top Glove Bhd (TGLVY) has a EBITDA Margin % of 17.07% as of May. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Top Glove Bhd and its competitors. This is 17% above median its historical median of 14.58. According to the industry distribution chart, Top Glove Bhd ranks #285 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 34.9%.
Is Top Glove Bhd's EBITDA Margin % too high?
Top Glove Bhd's current EBITDA Margin % of 17.07% is 17% above median its 10-year median of 14.58. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Top Glove Bhd's value of 17.07% is 128.4% above this industry median. Based on the distribution chart, Top Glove Bhd ranks #285 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Top Glove Bhd has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Top Glove Bhd's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Top Glove Bhd ranks #285 out of 816 companies for EBITDA Margin %. This puts Top Glove Bhd in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Top Glove Bhd's value of 17.07% is 128.4% above this benchmark. While the company's 10-year median is 14.58 vs. the industry median of 7.48, Top Glove Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Top Glove Bhd's current EBITDA Margin % of 17.07% is 128.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Top Glove Bhd and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Top Glove Bhd's current EBITDA Margin % is 17.07%, which is 17% above median its own 10-year median of 14.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Top Glove Bhd stock overvalued right now?
Based on GuruFocus' analysis, Top Glove Bhd (TGLVY) is currently considered Significantly Undervalued. The stock's GF Value™ is $1.19, compared to a current price of $0.70 — trading 40.9% below its estimated fair value. The current EBITDA Margin % is 17.07%, which is 17% above median its 10-year median of 14.58 and 128.4% above the Medical Devices & Instruments industry median of 7.48. Top Glove Bhd's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Top Glove Bhd (TGLVY), the current EBITDA Margin % is 17.07% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Top Glove Bhd (TGLVY) Overvalued in 2026?
Based on GuruFocus' analysis, Top Glove Bhd stock appears to be undervalued.
The current stock price of $0.70 is trading 40.9% below its estimated GF Value™ of $1.19.
GuruFocus considers Top Glove Bhd to be Significantly Undervalued.
Key valuation signals for TGLVY:
EBITDA Margin %: 17.07% (17% above median its 10-year median of 14.58)
GF Value™: $1.19 vs. price of $0.70 (40.9% below fair value)
Industry Position: 128.4% above the Medical Devices & Instruments median (#285 of 816)
No single metric tells the full story. See the TGLVY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Top Glove Corp Bhd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacturing and sales of gloves through several product lines to diverse customers in various countries. Some of the different glove options include latex, nitrile, vinyl, PE, Polychloroprene, Polyisoprene, Flexylon, HDPE and surgical. It serves various sectors including healthcare, industrial, and Food and Beverage sectors. The company has four reportable operating segments based on its geographical areas: Malaysia, Thailand, People's Republic of China and Others. The majority of revenue is generated from Malaysia.
73GF Score
Get the complete analysis for TGLVY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGLVY has been successfully added to your 
